We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$14.1B
1-Year Est. Return
30.11%
This Fund
S&P 500
This Quarter
Est. Return
+16.52%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$12B
AUM Growth
+$1.63B
(+16%)
Cap. Flow
+$315M
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
39.3%
Holding
1,552
New
107
Increased
840
Reduced
559
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$40.1M |
| 2 |
Microsoft
MSFT
|
+$34.8M |
| 3 |
NVIDIA
NVDA
|
+$33.9M |
| 4 |
AbbVie
ABBV
|
+$20M |
| 5 |
GE Aerospace
GE
|
+$19.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$20.3M |
| 2 |
Amazon
AMZN
|
+$19.9M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$17.7M |
| 4 |
Salesforce
CRM
|
+$15.8M |
| 5 |
Merck
MRK
|
+$15.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.48% |
| 2 | Financials | 11.87% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Communication Services | 10.18% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Iovance Biotherapeutics
IOVA
$2.31B
| $34.3K | ﹤0.01% |
19,940
-787
| -4% | -$1.96K |
|
1477
Community Health Systems
CYH
$454M
| $34.1K | ﹤0.01% |
+10,019
| New | +$32.2K |
|
|
BORR
1478
Borr Drilling
BORR
$1.3B
| $31.5K | ﹤0.01% |
17,234
-483
| -3% | -$913 |
|
1479
Bit Digital
BTBT
$551M
| $30.9K | ﹤0.01% |
+14,088
| New | +$31.1K |
|
|
NXDR
1480
Nextdoor Holdings
NXDR
$885M
| $30.8K | ﹤0.01% |
18,544
+6,000
| +48% | +$9.05K |
|
1481
Conduent
CNDT
$234M
| $30.2K | ﹤0.01% |
11,444
-242
| -2% | -$568 |
|
1482
Taysha Gene Therapies
TSHA
$1.63B
| $29.7K | ﹤0.01% |
12,837
+198
| +2% | +$430 |
|
1483
Butterfly Network
BFLY
$1.73B
| $29.5K | ﹤0.01% |
+14,764
| New | +$33.9K |
|
|
SVC
1484
Service Properties Trust
SVC
$1.11B
| $28.6K | ﹤0.01% |
2,395
-31
| -1% | -$335 |
|
1485
Sana Biotechnology
SANA
$868M
| $28.2K | ﹤0.01% |
+10,313
| New | +$21.3K |
|
1486
Standard BioTools
LAB
$320M
| $28.1K | ﹤0.01% |
23,402
+2,024
| +9% | +$2.24K |
|
1487
Clean Energy Fuels
CLNE
$467M
| $26.6K | ﹤0.01% |
13,622
+1,258
| +10% | +$2.14K |
|
1488
Pacific Biosciences
PACB
$429M
| $26.3K | ﹤0.01% |
21,195
+1,333
| +7% | +$1.54K |
|
1489
SelectQuote
SLQT
$126M
| $25.4K | ﹤0.01% |
10,654
+390
| +4% | +$1.02K |
|
1490
Solid Power
SLDP
$524M
| $24.7K | ﹤0.01% |
11,294
+632
| +6% | +$888 |
|
1491
Heron Therapeutics
HRTX
$88.5M
| $24.6K | ﹤0.01% |
+11,893
| New | +$24.3K |
|
1492
Gevo
GEVO
$426M
| $23.6K | ﹤0.01% |
+17,877
| New | +$20.9K |
|
|
OLPX
1493
DELISTED
Olaplex Holdings
OLPX
| $22.9K | ﹤0.01% |
+16,323
| New | +$21.3K |
|
1494
Cerus
CERS
$605M
| $22.4K | ﹤0.01% |
15,857
+857
| +6% | +$1.14K |
|
1495
Microvision
MVIS
$105M
| $21.8K | ﹤0.01% |
19,151
+3,719
| +24% | +$4.29K |
|
1496
Quantum-Si Incorporated
QSI
$174M
| $21.7K | ﹤0.01% |
+11,051
| New | +$16.3K |
|
1497
Getty Images
GETY
$201M
| $20.1K | ﹤0.01% |
+12,130
| New | +$21.4K |
|
1498
8x8 Inc
EGHT
$242M
| $19.7K | ﹤0.01% |
+10,074
| New | +$17.8K |
|
1499
Gossamer Bio
GOSS
$70.7M
| $18.1K | ﹤0.01% |
+14,677
| New | +$16K |
|
1500
Kopin
KOPN
$695M
| $17.7K | ﹤0.01% |
+11,584
| New | +$15.1K |
|
Similar funds
CM
BIP
FGP
BPC
SSA
TI
BBVA
IFP
Xponance's Q2 2025 Portfolio in Review
As of Q2 2025, Xponance held 1,552 positions worth $12B, up 16% from $10.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance's Q2 2025 filing shows 107 new, 840 increased, 559 reduced and 44 closed positions. Its largest new stake was Restaurant Brands International: 34,535 shares worth $2.29M. The largest sale was Alphabet (Google) Class A, an estimated $20.3M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Financials and Consumer Discretionary.
- Xponance's largest Q2 2025 buy was Restaurant Brands International: 34,535 shares worth $2.29M.
- Xponance added most to Apple in Q2 2025, an estimated $40.1M increase.
- Xponance's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $20.3M.
- Xponance fully exited Discover Financial Services in Q2 2025, selling an estimated $6.11M.
- Xponance's ten largest holdings make up 39% of its $12B portfolio in Q2 2025.
- Xponance opened 107 new positions and closed 44 in Q2 2025.
- Xponance's portfolio value rose 16% quarter-over-quarter to $12B.
Based on Xponance's 13F filing for Q2 2025, filed 14 Aug 2025.